• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy.

作者信息

Graafland Niels M, Szabados Bernadett, Tanabalan Chandran, Kuusk Teele, Mumtaz Faiz, Barod Ravi, Nicol David, Boleti Ekaterini, Powles Tom, Haanen John B, Bex Axel

机构信息

Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Renal Cancer Network, Amsterdam, The Netherlands.

Department of Medical Oncology, Barts Cancer Centre, London, UK.

出版信息

Eur Urol Oncol. 2022 Jun;5(3):373-374. doi: 10.1016/j.euo.2021.11.004. Epub 2021 Dec 20.

DOI:10.1016/j.euo.2021.11.004
PMID:34933813
Abstract
摘要

相似文献

1
Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy.基于免疫检查点抑制剂的双联联合疗法预处理后延期减瘤性肾切除术的手术安全性
Eur Urol Oncol. 2022 Jun;5(3):373-374. doi: 10.1016/j.euo.2021.11.004. Epub 2021 Dec 20.
2
Radical Nephrectomy After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.免疫检查点抑制剂治疗转移性肾细胞癌后的根治性肾切除术。
Eur Urol Focus. 2023 Mar;9(2):275-277. doi: 10.1016/j.euf.2023.01.022. Epub 2023 Feb 10.
3
A Swinging Pendulum: Bringing Back Cytoreductive Nephrectomy in the Era of Immune Checkpoint Inhibition.一个摆动的钟摆：在免疫检查点抑制时代恢复减瘤性肾切除术
Eur Urol Oncol. 2022 Oct;5(5):585-586. doi: 10.1016/j.euo.2022.07.009. Epub 2022 Aug 12.
4
Re: Daniel D. Shapiro, Jose A. Karam, Logan Zemp, et al. Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals. Eur Urol Open Sci 2023;50:43-6.回复：丹尼尔·D·夏皮罗、何塞·A·卡拉姆、洛根·曾普等。免疫检查点抑制剂治疗后减瘤性肾切除术安全且有助于延长无治疗间期。《欧洲泌尿外科开放科学》2023年；50卷：43 - 6页
Eur Urol. 2023 Aug;84(2):e53-e54. doi: 10.1016/j.eururo.2023.03.042. Epub 2023 May 5.
5
Re: Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium.回复：免疫检查点抑制剂或靶向治疗的转移性肾细胞癌的初始细胞减灭性肾切除术：来自国际转移性肾细胞癌数据库联盟的一项观察性研究
Eur Urol. 2023 Aug;84(2):244-245. doi: 10.1016/j.eururo.2023.03.034. Epub 2023 Apr 21.
6
Re: Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al. Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium. Eur Urol 2023;83:145-51.回复：齐亚德·巴库尼、塔拉勒·埃尔·扎里夫、沙恩·杜达尼等人。免疫检查点抑制剂或靶向治疗的转移性肾细胞癌的 upfront 减瘤性肾切除术：来自国际转移性肾细胞癌数据库联盟的一项观察性研究。《欧洲泌尿外科杂志》2023 年；83 卷：145 - 151 页。
Eur Urol. 2023 Sep;84(3):e75. doi: 10.1016/j.eururo.2023.04.040. Epub 2023 Jun 1.
7
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysis.免疫检查点抑制剂时代的细胞减灭性肾切除术：美国食品和药物管理局的汇总分析。
J Natl Cancer Inst. 2024 Jul 1;116(7):1043-1050. doi: 10.1093/jnci/djae066.
8
Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial.多中心随机对照试验：在接受检查点抑制剂治疗的同步转移性肾细胞癌中延迟细胞减灭性肾切除术：北欧-太阳试验。
BMC Cancer. 2024 Feb 24;24(1):260. doi: 10.1186/s12885-024-11987-3.
9
Impact of cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma receiving systemic tyrosine kinase inhibitor therapy: A multicenter retrospective study.原发转移性肾细胞癌患者接受系统酪氨酸激酶抑制剂治疗中细胞减灭性肾切除术的影响：一项多中心回顾性研究。
Int J Urol. 2021 Apr;28(4):369-375. doi: 10.1111/iju.14466. Epub 2020 Dec 12.
10
Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma.初始不可切除转移性透明细胞肾细胞癌患者接受检查点抑制剂免疫治疗后行择期细胞减瘤性肾切除术。
Clin Genitourin Cancer. 2020 Oct;18(5):361-366. doi: 10.1016/j.clgc.2020.04.002. Epub 2020 Apr 20.

引用本文的文献

1
Efficacy of presurgical therapy with tislelizumab and axitinib to downsize local lesions in locally advanced and metastatic renal cell carcinoma: a single-institution experience with long-term follow-up.替雷利珠单抗联合阿昔替尼术前治疗缩小局部晚期和转移性肾细胞癌局部病灶的疗效：单中心长期随访经验
Transl Androl Urol. 2025 Mar 30;14(3):651-660. doi: 10.21037/tau-24-585. Epub 2025 Mar 26.
2
Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies.新辅助免疫疗法在泌尿生殖系统恶性肿瘤中的作用。
Cancers (Basel). 2024 Dec 10;16(24):4127. doi: 10.3390/cancers16244127.
3
The effect of tumor downsizing on surgical complexity during nephrectomy after immune checkpoint inhibitors for metastatic renal cell carcinoma.
免疫检查点抑制剂治疗转移性肾细胞癌后肿瘤缩小对肾切除术手术复杂性的影响。
World J Urol. 2025 Jan 2;43(1):54. doi: 10.1007/s00345-024-05361-y.
4
Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review.肾切除术后高危肾细胞癌的围手术期全身治疗：一项叙述性综述
Transl Cancer Res. 2024 Nov 30;13(11):6511-6528. doi: 10.21037/tcr-24-16. Epub 2024 Jun 25.
5
Impact of presurgical systemic therapy on perioperative outcomes of renal cell carcinoma with inferior vena cava tumor thrombus.术前全身治疗对伴有下腔静脉瘤栓的肾细胞癌围手术期结局的影响
Int J Clin Oncol. 2025 Mar;30(3):532-538. doi: 10.1007/s10147-024-02680-3. Epub 2024 Dec 12.
6
Upfront versus deferred cytoreductive nephrectomy following targeted or immunotherapy: a population-based propensity score-matched analysis of perioperative complications.靶向或免疫治疗后即刻与延迟细胞减灭性肾切除术：基于人群的倾向性评分匹配分析围手术期并发症。
World J Urol. 2024 Jul 27;42(1):451. doi: 10.1007/s00345-024-05156-1.
7
Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma.接受全身免疫治疗的晚期肾细胞癌患者减瘤性肾切除术的手术结果
Urol Oncol. 2024 Feb;42(2):32.e9-32.e16. doi: 10.1016/j.urolonc.2023.12.003. Epub 2023 Dec 21.
8
Presurgical immune-oncology/tyrosine kinase inhibitor combination therapy for renal cell carcinoma with a vena cava tumor thrombus: a single-institution case series.术前免疫肿瘤学/酪氨酸激酶抑制剂联合治疗伴腔静脉瘤栓的肾细胞癌：单中心病例系列
Transl Androl Urol. 2023 Aug 31;12(8):1321-1325. doi: 10.21037/tau-23-203. Epub 2023 Aug 10.
9
The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma.转移性肾细胞癌中减瘤性肾切除术的发展态势
Cancers (Basel). 2023 Jul 29;15(15):3855. doi: 10.3390/cancers15153855.
10
Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals.免疫检查点抑制剂治疗后进行减瘤性肾切除术是安全的，并有助于延长无治疗间期。
Eur Urol Open Sci. 2023 Feb 18;50:43-46. doi: 10.1016/j.euros.2023.01.016. eCollection 2023 Apr.